Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies
- 4 January 2022
- journal article
- research article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 27 (1) , 175-187
Abstract
In a quest to discover new formulations for the treatment of various parasitic diseases, a series of heteroleptic triorganobismuth(V) biscarboxylates of type [BiR3(O2CR′)2], where R=C6H5 for 1–4 and p-CH3C6H4 for 5–8, were synthesized, characterized and evaluated for their biological potential against L. tropica. All the synthesized complexes were fully characterized by elemental analysis, FT-IR, multinuclear (1H and 13C) NMR spectroscopy and X-ray crystallography. The crystal structures for [BiPh3(O2CC6H4(o-Br))2] (1), [BiPh3(O2CC2H2C6H4)2] (2), [BiPh3(O2CC6H4(m-NO2))2] (3) and [BiPh3(O2CC6H4(2-OH,3-CH3))2] (4) were determined and found to have a distorted pentagonal bipyramidal molecular geometry with seven coordinated bismuth center for 1–3 and for 4 distorted octahedral geometry, respectively. All the synthesized complexes demonstrated a moderate to significant activity against leishmania parasites. A broad analytical approach was followed to testify the stability for (1–8) in solid state as well as in solution and in leishmanial culture M199, ensuring them to be stable enough to exert a significant antileishmanial effect with promising results. Cytotoxicity profile suggests that tris(tolyl) derivatives show lower toxicity against isolated lymphocytes with higher antileishmanial potential. Molecular docking studies were carried out to reveal the binding modes for (1–8) targeting the active site of trypanothione reductase (TR) (PDB ID: 4APN) and Trypanothione Synthetase-Amidase structure (PDB ID 2vob). Graphical abstractKeywords
Funding Information
- Higher Education Commission, Pakistan (21- 2465/SRGP/R&D/HEC/2019)
This publication has 58 references indexed in Scilit:
- Anti-Leishmanial Activity of Novel Homo- and Heteroleptic Bismuth(iii) ThiocarboxylatesAustralian Journal of Chemistry, 2013
- Bismuth 2,6-pyridinedicarboxylates: Assembly of molecular units into coordination polymers, CO2 sorption and photoluminescenceDalton Transactions, 2012
- Iron–sulfur cluster biosynthesis: characterization of IscU–IscS complex formation and a structural model for sulfide delivery to the [2Fe–2S] assembly siteJBIC Journal of Biological Inorganic Chemistry, 2009
- Synthetic and structural comparisons of bismuth(iii) carboxylates synthesised under solvent-free and reflux conditionsDalton Transactions, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprineAlimentary Pharmacology & Therapeutics, 2001
- WinGXsuite for small-molecule single-crystal crystallographyJournal of Applied Crystallography, 1999
- Purification of Laboratory Chemicals, Fourth Edition. By W. L. F. ArmaregoMolecules, 1997
- Synthesis and Structure of Seven‐Coordinate Bismuth(V) Complexes with Benzenoid and Non‐Benzenoid Arene Ligands: Tri(aryl)tropolonatobismuth(V) ComplexesAngewandte Chemie International Edition, 1996
- Molecular recognition of receptor sites using a genetic algorithm with a description of desolvationJournal of Molecular Biology, 1995